Ñî¹óåú´«Ã½

ACP does not support QPP measure 377: "Functional Status Assessment for Patients with CHF." It is unclear whether implementation of this measure will lead to meaningful improvements in quality outcomes and the measure developers do not cite a performance gap. While implementation may promote appropriate care by helping clinicians identify patients in need of further intervention, incentivizing clinicians to perform routine assessments in asymptomatic patients may result in underuse of more meaningful clinical interventions. While we support the development and implementation of valid, reliable patient reported outcome measures (PROMs), there is insufficient evidence to support the benefit of this intervention on quality outcomes. Implementation of evidence-based PROMs using validated instruments to assess clinical performance is likely the first step towards collecting PRO data. As currently specified, congestive heart failure is not clearly defined. Developers should consider revising the specifications to clearly differentiate between preserved ejection fraction and systolic dysfunction because this intervention will more likely lead to quality improvements in the latter population.